Filing Flows › IQVIA Holdings (IQV) › Q3 2026 › vs Q3 2025
IQVIA Holdings (IQV) Q3 2026 vs Q3 2025 (year over year)
IQVIA Holdings's revenue rose $328M (+8%) from $4.1B in Q3 2025 to $4.4B in Q3 2026. The biggest changes: Research & Development Solutions +$212M (+9%); Commercial Solutions +$116M (+7%). Operating margin 12.9% against 13.5% (-0.6 pts).
IQVIA Holdings, Q3 2026: revenue $4.4B (+8% year over year), operating margin 12.9%, net earnings $352M, operating cash flow $825M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 12.9% | 13.5% | -0.6 pts |
| Net margin | 7.9% | 8.1% | -0.1 pts |
| Free cash flow margin | 15.1% | 18.8% | -3.8 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Research & Development Solutions | $2.6B | $2.4B | $212M | +9% |
| Commercial Solutions | $1.8B | $1.7B | $116M | +7% |
| Revenue | $4.4B | $4.1B | $328M | +8% |
| Operating profit | $572M | $553M | $19.0M | +3% |
| Costs & expenses | $3.9B | $3.5B | $309M | +9% |
| Pre-tax earnings | $428M | $408M | $20.0M | +5% |
| Other expense, net | $144M | $145M | −$1.0M | -0.7% |
| Cost of revenue | $2.9B | $2.7B | $203M | +7% |
| SG&A | $569M | $514M | $55.0M | +11% |
| Other operating costs | $357M | $306M | $51.0M | +17% |
| Net earnings | $352M | $332M | $20.0M | +6% |
| Income tax | $76.0M | $76.0M | $0 | 0% |
| Depreciation & amortization | $321M | $286M | $35.0M | +12% |
| Share-based compensation | $83.0M | $55.0M | $28.0M | +51% |
| Working capital & other | $69.0M | $235M | −$166M | -71% |
| Operating cash flow | $825M | $908M | −$83.0M | -9% |
| Free Cash Flow (company-reported) | $667M | $772M | −$105M | -14% |
| Acquisition of property, equipment and software | $158M | $136M | $22.0M | +16% |
Questions
How much did IQVIA Holdings's revenue grow year over year in Q3 2026?
IQVIA Holdings's revenue rose $328M (+8%) from $4.1B in Q3 2025 to $4.4B in Q3 2026.
What drove IQVIA Holdings's revenue change in Q3 2026?
Research & Development Solutions +$212M (+9%); Commercial Solutions +$116M (+7%).